Success Metrics

Clinical Success Rate
90.9%

Based on 10 completed trials

Completion Rate
91%(10/11)
Active Trials
2(12%)
Results Posted
50%(5 trials)
Terminated
1(6%)

Phase Distribution

Ph not_applicable
6
35%
Ph phase_1
1
6%
Ph phase_2
4
24%
Ph phase_4
2
12%
Ph phase_3
4
24%

Phase Distribution

1

Early Stage

4

Mid Stage

6

Late Stage

Phase Distribution17 total trials
Phase 1Safety & dosage
1(5.9%)
Phase 2Efficacy & side effects
4(23.5%)
Phase 3Large-scale testing
4(23.5%)
Phase 4Post-market surveillance
2(11.8%)
N/ANon-phased studies
6(35.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

10 of 12 finished

Non-Completion Rate

16.7%

2 ended early

Currently Active

2

trials recruiting

Total Trials

17

all time

Status Distribution
Active(4)
Completed(10)
Terminated(2)
Other(1)

Detailed Status

Completed10
Not yet recruiting2
Terminated1
Withdrawn1
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
2
Success Rate
90.9%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (5.9%)
Phase 24 (23.5%)
Phase 34 (23.5%)
Phase 42 (11.8%)
N/A6 (35.3%)

Trials by Status

terminated16%
withdrawn16%
unknown16%
not_yet_recruiting212%
active_not_recruiting16%
completed1059%
recruiting16%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT03927027Phase 3

Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection

Active Not Recruiting
NCT04109079Not Applicable

Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant Chemotherapy

Recruiting
NCT05970107Not Applicable

Axillary Node Dissection w or w/o LVB in Node Positive Breast Cancer Patients

Not Yet Recruiting
NCT06869629Not Applicable

Omission of Axillary Lymph Node Dissection in Case of Tumor Spread to Lymph Nodes in the Armpit in Breast Cancer

Not Yet Recruiting
NCT00556777Not Applicable

Radiation Therapy During Surgery in Treating Older Women With Stage I Breast Cancer

Completed
NCT02689427Phase 2

Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer

Completed
NCT00881361Phase 2

Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer

Completed
NCT03038152Phase 4

Magseed Magnetic Marker in Locating Axillary Lymph Nodes in Patients With Breast Cancer Undergoing Surgery

Completed
NCT00003855Phase 3

Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer

Completed
NCT01796444Phase 3

Axillary Lymph Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node

Withdrawn
NCT01642511Phase 2

Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Negative

Completed
NCT00072293Not Applicable

Surgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node Micrometastases

Completed
NCT00932035Phase 1

Axillary Lymph Node Preservation Surgery in Reducing Lymphedema in Patients With Breast Cancer

Terminated
NCT00450723Not Applicable

Thoracoscopic Sentinel Lymph Node Biopsy in Patients With Stage I or Stage II Breast Cancer

Completed
NCT01381315Phase 2

Axillary Reverse Mapping

Completed
NCT02781259Phase 4

Selective Lymph Node Dissection Using Fluorescent Dye in Node-positive Breast Cancer

Unknown
NCT00014612Phase 3

Comparison of Complete Axillary Lymph Node Dissection With Axillary Radiation Therapy in Treating Women With Invasive Breast Cancer

Completed

All 17 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
17